Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1971 Sep 11;3(5775):599–604. doi: 10.1136/bmj.3.5775.599

Trial of Maintenance Therapy in Schizophrenia*

J P Leff, J K Wing
PMCID: PMC1798790  PMID: 4936538

Abstract

A double-blind, placebo-controlled trial was carried out to determine the value of maintenance therapy with phenothiazines in a population of outpatients who had recently recovered from an acute episode of schizophrenia. The drug was shown to be significantly more effective than the placebo in preventing relapse. The relationship of the trial patients to the population from which they were selected was defined in terms of clinical, historical, and social data. Maintenance therapy seems of little value in patients with a good prognosis and in the severely ill, but it is of value in the indeterminate group between these two extremes.

Full text

PDF
599

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asberg M., Cronholm B., Sjöqvist F., Tuck D. Correlation of subjective side effects with plasma concentrations of nortriptyline. Br Med J. 1970 Oct 3;4(5726):18–21. doi: 10.1136/bmj.4.5726.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Curry S. H., Davis J. M., Janowsky D. S., Marshall J. H. Factors affecting chlorpromazine plasma levels in psychiatric patients. Arch Gen Psychiatry. 1970 Mar;22(3):209–215. doi: 10.1001/archpsyc.1970.01740270017002. [DOI] [PubMed] [Google Scholar]
  3. DIAMOND L. S., MARKS J. B. Discontinuance of tranquilizers among chronic schizophrenic patients receiving maintenance dosage. J Nerv Ment Dis. 1960 Sep;131:247–251. doi: 10.1097/00005053-196009000-00006. [DOI] [PubMed] [Google Scholar]
  4. ENGELHARDT D. M., FREEDMAN N., ROSEN B., MANN D., MARGOLIS R. PHENOTHIAZINES IN PREVENTION OF PSYCHIATRIC HOSPITALIZATION. 3. DELAY OR PREVENTION OF HOSPITALIZATION. Arch Gen Psychiatry. 1964 Aug;11:162–169. doi: 10.1001/archpsyc.1964.01720260056007. [DOI] [PubMed] [Google Scholar]
  5. ENGELHARDT D. M., ROSEN B., FREEDMAN N., MANN D., MARGOLIS R. PHENOTHIAZINES IN PREVENTION OF PSYCHIATRIC HOSPITALIZATION. II. DURATION OF TREATMENT EXPOSURE. JAMA. 1963 Dec 14;186:981–983. doi: 10.1001/jama.1963.03710110033006. [DOI] [PubMed] [Google Scholar]
  6. GOOD W. W., STERLING M., HOLTZMAN W. H. Termination of chlorpromazine with schizophrenic patients. Am J Psychiatry. 1958 Nov;115(5):443–448. doi: 10.1176/ajp.115.5.443. [DOI] [PubMed] [Google Scholar]
  7. GROSS M. The impact of ataractic drugs on a mental hospital outpatient clinic. Am J Psychiatry. 1960 Nov;117:444–447. doi: 10.1176/ajp.117.5.444. [DOI] [PubMed] [Google Scholar]
  8. GUTTMACHER M. S. PHENOTHIAZINE TREATMENT IN ACUTE SCHIZOPHRENIA; EFFECTIVENESS: THE NATIONAL INSTITUTE OF MENTAL HEALTH PSYCHOPHARMACOLOGY SERVICE CENTER COLLABORATIVE STUDY GROUP. Arch Gen Psychiatry. 1964 Mar;10:246–261. [PubMed] [Google Scholar]
  9. Gibberd F. B., Dunne J. F., Handley A. J., Hazleman B. L. Supervision of epileptic patients taking phenytoin. Br Med J. 1970 Jan 17;1(5689):147–149. doi: 10.1136/bmj.1.5689.147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. LUNTZ G. R., AUSTIN R. New stick test for P.A.S. in urine. Report on use of "phenistix" and problems of long-term chemotherapy for tuberculosis. Br Med J. 1960 Jun 4;1(5187):1679–1684. doi: 10.1136/bmj.1.5187.1679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. PARKES C. M., BROWN G. W., MONCK E. M. The general practitioner and the schizophrenic patient. Br Med J. 1962 Apr 7;1(5283):972–976. doi: 10.1136/bmj.1.5283.972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. PASAMANICK B., SCARPITTI F. R., LEFTON M., DINITZ S., WERNERT J. J., MCPHEETERS H. HOME VS HOSPITAL CARE FOR SCHIZOPHRENICS. JAMA. 1964 Jan 18;187:177–181. doi: 10.1001/jama.1964.03060160005001. [DOI] [PubMed] [Google Scholar]
  13. RATHOD N., REES L. A controlled study of the prognostic significance of autonomic responses in the chlorpromazine treatment of disturbed psychotic patients. J Ment Sci. 1958 Jul;104(436):705–712. doi: 10.1192/bjp.104.436.705. [DOI] [PubMed] [Google Scholar]
  14. SHAWVER J. R., GORHAM D. R., LESKIN L. W., GOOD W. W., KABNICK D. E. Comparison of chlorpromazine and reserpine in maintenance drug therapy. Dis Nerv Syst. 1959 Oct;20:452–457. [PubMed] [Google Scholar]
  15. Willcox D. R., Gillan R., Hare E. H. Do psyhiatric out-patients take their drugs? Br Med J. 1965 Oct 2;2(5465):790–792. doi: 10.1136/bmj.2.5465.790. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Wing J. K., Birley J. L., Cooper J. E., Graham P., Isaacs A. D. Reliability of a procedure for measuring and classifying "present psychiatric state". Br J Psychiatry. 1967 May;113(498):499–515. doi: 10.1192/bjp.113.498.499. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES